Erik L. Ridley and Philip Ward[email protected]AIRadNet broadens AI focus with acquisitions of Aidence, QuantibImaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesCTUsing GPT‑4o with CT exams helps diagnose ovarian cancer earlierEarly detection of ovarian cancer is a persistent challenge, with more than half still diagnosed at metastatic stages.Womens ImagingSurvey: Nearly 4 out of 5 practices short on breast imagersRadiation Oncology/TherapyPooled evidence: Lu-177 PSMA-617 vs. established therapies in mCRPCMRICardiac MRI-based ML model predicts MACE risk for STEMI patientsSponsor ContentHow Agentic AI Is Transforming Radiology Ops